Skip to main content
Acta Crystallographica Section F: Structural Biology and Crystallization Communications logoLink to Acta Crystallographica Section F: Structural Biology and Crystallization Communications
. 2010 Aug 21;66(Pt 9):973–977. doi: 10.1107/S1744309110025601

The structure of a family GH25 lysozyme from Aspergillus fumigatus

Justyna E Korczynska a, Steffen Danielsen b, Ulrika Schagerlöf b, Johan P Turkenburg a, Gideon J Davies a, Keith S Wilson a,*, Edward J Taylor a,*
PMCID: PMC2935209  PMID: 20823508

The X-ray structure of a fungal lysozyme shows a modified α/β-barrel-like fold and a likely active-site DXE motif.

Keywords: lysozymes, lysins, peptidoglycan cleavage, fungal GH25

Abstract

Lysins are important biomolecules which cleave the bacterial cell-wall polymer peptidoglycan. They are finding increasing commercial and medical application. In order to gain an insight into the mechanism by which these enzymes operate, the X-ray structure of a CAZy family GH25 ‘lysozyme’ from Aspergillus fumigatus was determined. This is the first fungal structure from the family and reveals a modified α/β-barrel-like fold in which an eight-stranded β-barrel is flanked by three α-helices. The active site lies toward the bottom of a negatively charged pocket and its layout has much in common with other solved members of the GH25 and related GH families. A conserved active-site DXE motif may be implicated in catalysis, lending further weight to the argument that this glycoside hydrolase family operates via a ‘substrate-assisted’ catalytic mechanism.

1. Introduction

Lysins are important biomolecules that cleave the bacterial cell-wall polymer peptidoglycan at a variety of different positions. The term ‘lysozyme’ is broadly used to describe enzymes that cleave the β-­1,4-glycosidic bond between N-acetylglucosamine (NAG) and N-acetyl­muramic acid (NAM) (or vice versa) in the carbohydrate backbone of peptidoglycan (Fig. 1 a). There is increasing interest in the potential of such lytic enzymes as antimicrobial agents. This reflects their exquisite efficiency (Nelson et al., 2001) and potential specificity for specific bacteria. In this context, lysozyme activity against medically relevant pathogens has been shown to include Streptococcus pneumoniae (Loeffler et al., 2003), Bacillus anthracis (Schuch et al., 2002) and Enterococcus faecium (Yoong et al., 2004). Lysins have also found applications in cheese manufacture (de Ruyter et al., 1997) and in the killing of Listeria in food preparations (for a recent example, see Soni et al., 2010).

Figure 1.

Figure 1

(a) Generic reaction of a ‘lyzozyme’: cleavage of one of the β-1,4 glycosidic bonds in the backbone of peptidoglycan (R indicates possible peptide cross-links and R′ indicates possible O-acetylation). (b) Three-dimensional protein cartoon of AfGH25 with the putative catalytic residues Asp105 and Glu107 shown in ball-and-stick representation. (c) Electrostatic surface representation of AfGH25 in the same orientation as in (b). The active-site residues are located towards the bottom of a highly negatively charged ‘pit’. (d) Divergent (‘wall-eyed’) stereo representation of the overlap of AfGH25 (pale green) with the Streptococcus pneumoniae phage enzyme in complex with peptidoglycan fragments (blue; Hermoso et al., 2003; Perez-Dorado et al., 2007). The negatively charged and aromatic residues of AfGH25 referred to in the text are shown, with the putative catalytic residues Asp105 and Glu107 labelled.

In nature, the β-1,4 bonds of peptidoglycan are cleaved by a structurally diverse set of enzymes in terms of biochemical and structural properties which have been classified into five homology families (CAZy; http://www.cazy.org; Cantarel et al., 2008): hen egg-white lysozyme (HEWL; GH22 family), goose egg-white lysozyme (GEWL; GH23), bacteriophage T4 lysozyme (T4L; GH24), Sphingo­monas flagellar protein (FlgJ; GH73; Hashimoto et al., 2009) and Chalaropsis lysozymes (GH25). A sixth family GH108 is likely to emerge, although it remains largely biochemically uncharacterized. The first three types share common structural features but with very low sequence identities: these enzymes consist of a constant core of two helices and a three-stranded β-sheet that accommodates the substrates in the inter-domain cleft (Monzingo et al., 1996).

The Chalaropsis ‘class’ of lysozymes, family GH25, are structurally unrelated to the other lysozyme folds. These enzymes display a modified α/β-barrel-like fold in which an eight-stranded β-barrel is flanked by just three α-helices (Rau et al., 2001). This family exhibits both β-1,4-N-acetylmuramidase and β-1,4-N,6-O-diacetylmurami­dase activities (Felch et al., 1975), and its evolutionary spread is diverse, comprising bacterial, viral (mainly phage) and eukaryotic representatives. To date, four members have been structurally characterized: B. anthracis BaGH25c (Martinez-Fleites et al., 2009), Streptomyces coelicolor cellosyl (Rau et al., 2001), the bacteriophage lysin PlyB (Porter et al., 2007) and Clp-1 lysozyme from a Streptococcus pneumoniae phage (Hermoso et al., 2003; Perez-Dorado et al., 2007), with only the latter being in a complex with peptidoglycan fragments (Perez-Dorado et al., 2007). There is still a lack of experimental studies on the catalytic mechanism of GH25 enzymes, with no three-dimensional structure of a eukaryotic representative having been obtained to date; the properties of eukaryotic representatives have been inferred from those of bacterial homologues together with mutagenesis data. Here, we report the crystal structure of the fungal GH25 from Aspergillus fumigatus (hereafter referred to as AfGH25) at a resolution of 1.7 Å. We show that the enzyme is similar to viral and prokaryotic GH25 enzymes (Martinez-Fleites et al., 2009) with an active site that is consistent with catalysis occurring via a ‘neighbouring-group’ mechanism (Vocadlo & Davies, 2008) with net retention of anomeric configuration.

2. Materials and methods

2.1. Cloning, expression and purification

The open reading frame encoding the afgh25 gene (http://www.uniprot.org/uniprot/A4DA29.html) was amplified with the in­clusion of the wild-type secretion signal (MKFSIVAIATIAGLA­SA) from an A. fumigatus strain Af293 cDNA pMWRAfum25C plasmid library (provided by Alfredo de Lopez, Novozymes Biotech Inc.) and the primer pair SteD1597NotI, 5′-ATAGCGGCCGCACCATGAAGTTCTCTATCGTTGCCATTGCCAC, and SteD1594XhoI, 5′-AATCTCGAGTTAACCACTGGCTAACTTCCTCAACTGG, using PCR. The reaction was performed using Pwo polymerase (Boehringer Mannheim) and yielded a single PCR product of the predicted 745 base-pair size. The PCR product was purified and digested with the restriction endonucleases NotI and XhoI (New England Biolabs) and the fragment was subsequently ligated into the pre-digested A. oryzae expression vector pENI1898. The ligation was transformed into competent Escherichia coli DH10B cells and DNA purified from selected colonies. The integrity of the construct was verified by DNA-sequence analysis and the plasmid was transformed into A. oryzae ToC1512 for expression purposes. Transformants were spore-purified twice and submitted to fermentation. Protein expression was targeted towards the culture medium by the secretion signal and was con­firmed by SDS–PAGE of the medium, which showed a protein band migrating at the expected rate for the molecular size.

2.2. Purification of the GH25 lysozyme

Culture broths were filtered through a filtration cloth and subsequently through a 0.2 µm filtration unit (Nalgene) to remove the Aspergillus host. Solid NaCl was added to a final concentration of 400 mM and the pH was adjusted to pH 5.5 with 20% acetic acid. The adjusted enzyme solution was applied onto an SP Sepharose FF column (GE Healthcare) which was equilibrated in 50 mM acetic acid/NaOH, 200 mM NaCl pH 5.5. The column was thoroughly washed with equilibration buffer to remove loosely bound protein. The enzyme was then eluted using a linear NaCl gradient (200–1000 mM) in 50 mM acetic acid/NaOH pH 5.5 over five column volumes. The GH25 lysozyme eluted as a single peak and its purity was analyzed by SDS–PAGE. The resultant protein preparation was concentrated to 26 mg ml−1 and buffer-exchanged into 25 mM HEPES pH 7.5 using a Vivaspin 10 kDa cutoff concentrator.

2.3. Crystallization and structure solution

Crystals of AfGH25 were grown in 96-well MRC Crystallization Plates (Molecular Dimensions Ltd) holding a reservoir volume of 60 µl crystallization solution. Drops were set up using a Mosquito Nanodrop crystallization robot (Molecular Dimensions Ltd) by mixing 150 nl protein solution with 150 nl crystallization solution. Crystals grew in 0.1 M MIB (malonic acid, imidazole, boric acid) system pH 4.0 and 25%(w/v) PEG 3350, corresponding to conditions B1–B4 of the PACT premier screen (Molecular Dimensions Ltd). Crystals were harvested directly from the MRC plate and cryoprotected by bathing them in mother-liquor solution incorporating 25% glycerol prior to flash-cooling them in liquid nitrogen. Diffraction data were collected to 1.7 Å resolution at 100 K on beamline ID23-1 at the European Synchrotron Radiation Facility (ESRF) at a wavelength of 0.976 Å. Data were processed with MOSFLM (Leslie, 1992) and scaled in SCALA (Collaborative Computational Project, Number 4, 1994). The structure was solved by molecular replacement using Phaser (McCoy et al., 2007), with the coordinates of Streptomyces coelicolor lysozyme (PDB code 1jfx; Rau et al., 2001), which shares approximately 51% amino-acid sequence identity (Altschul et al., 1997) with AfGH25, as a search model. The starting model was improved manually using Coot (Emsley & Cowtan, 2004) between cycles of REFMAC (Murshudov et al., 1997). The structure was validated using MolProbity (Chen et al., 2010) prior to deposition. Data-collection and refinement statistics are given in Table 1. The refined structure was deposited in the PDBe database (http://www.ebi.ac.uk/pdbe) under code 2x8r. Structural figures were pro­duced with PyMOL (DeLano, 2002) and MolScript (Kraulis, 1991).

Table 1. AfGH25 X-ray data and refinement statistics.

Values in parentheses are for the outer shell.

Data processing
 Space group P212121
 Unit-cell parameters (Å) a = 80.7, b = 111.8, c = 119.2
 Wavelength (Å) 0.97600
 Molecules in asymmetric unit 6
 Resolution range (Å) 40.75–1.70 (1.79–1.70)
Rmerge 0.088 (0.371)
 〈I〉/〈σ(I)〉 13.0 (3.0)
 Completeness (%) 99.9 (99.5)
 Redundancy 6.3 (3.9)
Refinement statistics
 No. of reflections 18715
Rcryst 0.17
Rfree 0.21
 Mean B values
  Protein atoms (Å2) 13
  Ligand/ion atoms (Å2) 11
  Solvent atoms (Å2) 24
 R.m.s.d. bonds (Å) 0.018
 R.m.s.d angles (°) 1.57
 Ramachandran statistics (%)
  Preferred regions 96.28
  Allowed regions 3.12
  Outliers 0.61
 PDB code 2x8r

3. Results and discussion

The crystals of AfGH25 belonged to the orthorhombic space group P212121, with unit-cell parameters a = 80.7, b = 111.8, c = 119.2 Å and six molecules in the asymmetric unit (Table 1). The chains were traced from Tyr10 through to Gly211 in all six molecules, with an ion, modelled as Cl, associated with each molecule. 1105 water molecules have also been modelled. As for other GH25 lysozymes (see below), the AfGH25 structure is a modified α/β-barrel fold built from eight β-strands and three α-helices (Fig. 1 b). A structural similarity analysis against other solved members of CAZy family GH25 was carried out using Coot. The closest related structure was that of the bacterial lysozyme from S. coelicolor (1 Å r.m.s.d. over 206 Cα atoms), followed by that from B. anthracis (1.6 Å r.m.s.d. over 187 Cα atoms) and those of CP-1, a cell-wall endolysin from Streptococcus pneumoniae (2.1 Å r.m.s.d. over 169 Cα atoms), and PlyB, a bacterio­phage-encoded lysin (2.0 Å r.m.s.d. over 173 Cα atoms). Despite relatively low sequence identities among the structurally characterized GH25 members (18–51%), strong conservation is observed at the C-termini of the β-strands and this location corresponds to the entrance of the catalytic cavity. In AfGH25, as in the other GH25 members, this cavity is lined by a constellation of negatively charged residues (Asp16, Asp105, Glu107, Asp194 and Asp201; Figs. 1 c and 1 d) and aromatic residues (Tyr69, Phe71, Tyr108, Tyr145 and Tyr172; Fig. 1 d).

Superposition of the AfGH25 coordinates onto the structure of the complex of Clp-1 lysozyme with a peptidoglycan analogue shows no conservation around the residues that bind the sugar moieties in subsites +1 and +2 (Fig. 1 d; the glycoside hydrolase subsite nomenclature is as in Davies et al., 1997). The loops surrounding these sites adopt different conformations in the two enzymes, so that in the absence of a complex structure the structural determinants that underlie the specificity of the AfGH25 enzyme remain uncertain.

Our recent studies on the BaGH25 lysozyme suggest a mechanism for GH25 (Martinez-Fleites et al., 2009) in which catalysis proceeds through an oxazoline intermediate. Evidence for this arises from the conservation of sequence similarities within the GH25 family (Fig. 2) and the resemblance that this architecture bears to other retaining hydrolases belonging to families GH18, GH20, GH56, GH84 and GH85 (Fig. 3; Martinez-Fleites et al., 2009; recently reviewed in Martinez-Fleites et al., 2010). These families have been shown to have an active-site DE or DXE sequence motif. The DE carboxylate pair promotes a double-displacement mechanism in which the nucleophile is not enzyme-derived but instead lies on the intramolecular ‘neighbouring group’ of the N-acetyl carbonyl group (Vocadlo & Davies, 2008). Catalysis occurs via the formation and subsequent breakdown of a covalent oxazoline intermediate. There is clear structural con­servation in the putative −1 site in all structurally characterized GH25 enzymes which not only involves the presumed catalytic residues but also several aromatic residues that form a well defined pocket whose entrance is about 7 Å wide and 10 Å deep. We suggest that Asp105 and Glu107 act as the signature catalytic constellation in AfGH25. We propose Asp105 to be the catalytic acid/base, initially protonating the leaving group to facilitate its departure (general acid assistance) and subsequently acting as a general base to activate the hydrolytic water molecule. Glu107 acts to stabilize or deprotonate the oxazoline N atom (Martinez-Fleites et al., 2009).

Figure 2.

Figure 2

A Multalin (http://multalin.toulouse.inra.fr/multalin/) sequence alignment of known GH25 structures. Conserved residues are shown in red and asterisks denote the positions of the putative catalytic residues Asp105 and Glu107 which make up part of the DXE motif.

Figure 3.

Figure 3

Superposition of the catalytic cavities of retaining hydrolases belonging to families GH20 (yellow; PDB code 1np0; Mark et al., 2003), GH84 (purple; PDB code 2chn; Dennis et al., 2006) and GH85 (blue; PDB code 2w92; Abbott et al., 2009) and BaGH25c (green) around the coordinates of their NAG-thiazoline (NTZ) complexes.

The biological role of the AfGH25 enzyme has yet to be established. The presence of an N-terminal signal secretion peptide indicates the location of AfGH25 to be extracellular, so it can be speculated that the molecule may act as a selective agent by possessing antimicrobial activity or may possibly serve as a tool for the breakdown of bacterial peptidoglycan for nutritional purposes. This may either be by the direct assimilation of bacterial cell-wall components or as part of a mechanism to improve access to the content of the bacterial cell. The growing concern related to the spread of multi-drug-resistant bacteria caused by classical small-molecule ‘drug’-based antimicrobial treatments makes lysins an interesting candidate for a novel type of antibacterial agent. Since these enzymes target the bacterial cell wall, the occurrence of bacterial resistance developed owing to multiple exposures would be less likely. Thus, from an applied perspective it appears as if lysins have many of the desired characteristics required, such as efficacy, specificity and biodegradability.

Supplementary Material

PDB reference: family GH25 lysozyme, 2x8r

Acknowledgments

We gratefully acknowledge financial support from the Royal Society and the Biotechnology and Biological Sciences Research Council (BBSRC) and from Novozymes A/S. GJD is a Royal Society/Wolfson Research Merit Award recipient. pMWRAfum25C was kindly provided by Alfredo de Lopez, Novozymes Biotech Inc.

References

  1. Abbott, D. W., Macauley, M. S., Vocadlo, D. J. & Boraston, A. B. (2009). J. Biol. Chem.284, 11676–11689. [DOI] [PMC free article] [PubMed]
  2. Altschul, S. F., Madden, T. L., Schäffer, A. A., Zhang, J., Zhang, Z., Miller, W. & Lipman, D. J. (1997). Nucleic Acids Res.25, 3389–3402. [DOI] [PMC free article] [PubMed]
  3. Cantarel, B. L., Coutinho, P. M., Rancurel, C., Bernard, T., Lombard, V. & Henrissat, B. (2008). Nucleic Acids Res.37, D233–D238. [DOI] [PMC free article] [PubMed]
  4. Chen, V. B., Arendall, W. B., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., Murray, L. W., Richardson, J. S. & Richardson, D. C. (2010). Acta Cryst. D66, 12–21. [DOI] [PMC free article] [PubMed]
  5. Collaborative Computational Project, Number 4 (1994). Acta Cryst. D50, 760–763.
  6. Davies, G. J., Wilson, K. S. & Henrissat, B. (1997). Biochem. J.321, 557–559. [DOI] [PMC free article] [PubMed]
  7. DeLano, W. L. (2002). PyMOL Molecular Viewer. http://www/pymol.org.
  8. Dennis, R. J., Taylor, E. J., Macauley, M. S., Stubbs, K. A., Turkenburg, J. P., Hart, S. J., Black, G. N., Vocadlo, D. J. & Davies, G. J. (2006). Nature Struct. Mol. Biol.13, 365–371. [DOI] [PubMed]
  9. Emsley, P. & Cowtan, K. (2004). Acta Cryst. D60, 2126–2132. [DOI] [PubMed]
  10. Felch, J. W., Inagami, T. & Hash, J. H. (1975). J. Biol. Chem.250, 3713–3720. [PubMed]
  11. Hashimoto, W., Ochiai, A., Momma, K., Itoh, T., Mikami, B., Maruyama, Y. & Murata, K. (2009). Biochem. Biophys. Res. Commun.381, 16–21. [DOI] [PubMed]
  12. Hermoso, J. A., Monterroso, B., Albert, A., Galan, B., Ahrazem, O., Garcia, P., Martinez-Ripoll, M., Garcia, J. L. & Menendez, M. (2003). Structure, 11, 1239–1249. [DOI] [PubMed]
  13. Kraulis, P. J. (1991). J. Appl. Cryst.24, 946–950.
  14. Leslie, A. G. W. (1992). Jnt CCP4/ESF–EACBM Newsl. Protein Crystallogr.26
  15. Loeffler, J. M., Djurkovic, S. & Fischetti, V. A. (2003). Infect. Immun.71, 6199–6204. [DOI] [PMC free article] [PubMed]
  16. Mark, B. L., Mahuran, D. J., Cherney, M. M., Zhao, D., Knapp, S. & James, M. N. G. (2003). J. Mol. Biol.327, 1093–1109. [DOI] [PMC free article] [PubMed]
  17. Martinez-Fleites, C., He, Y. & Davies, G. J. (2010). Biochim. Biophys. Acta, 1800, 122–133. [DOI] [PubMed]
  18. Martinez-Fleites, C., Korczynska, J. E., Davies, G. J., Cope, M. J., Turkenburg, J. P. & Taylor, E. J. (2009). Carbohydr. Res.344, 1753–1757. [DOI] [PubMed]
  19. McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C. & Read, R. J. (2007). J. Appl. Cryst.40, 658–674. [DOI] [PMC free article] [PubMed]
  20. Monzingo, A. F., Marcotte, E. M., Hart, P. J. & Robertus, J. D. (1996). Nature Struct. Biol.3, 133–140. [DOI] [PubMed]
  21. Murshudov, G. N., Vagin, A. A. & Dodson, E. J. (1997). Acta Cryst. D53, 240–255. [DOI] [PubMed]
  22. Nelson, D., Loomis, L. & Fischetti, V. A. (2001). Proc. Natl Acad. Sci. USA, 98, 4107–4112. [DOI] [PMC free article] [PubMed]
  23. Perez-Dorado, I., Campillo, N. E., Monterroso, B., Hesek, D., Lee, M., Paez, J. A., Garcia, P., Martinez-Ripoll, M., Garcia, J. L., Mobashery, S., Menendez, M. & Hermoso, J. A. (2007). J. Biol. Chem.282, 24990–24999. [DOI] [PubMed]
  24. Porter, C. J., Schuch, R., Pelzek, A. J., Buckle, A. M., McGowan, S., Wilce, M. C., Rossjohn, J., Russell, R., Nelson, D., Fischetti, V. A. & Whisstock, J. C. (2007). J. Mol. Biol.366, 540–550. [DOI] [PubMed]
  25. Rau, A., Hogg, T., Marquardt, R. & Hilgenfeld, R. (2001). J. Biol. Chem.276, 31994–31999. [DOI] [PubMed]
  26. Ruyter, P. de, Kuipers, O. P., Meijer, W. C. & de Vos, W. M. (1997). Nature Biotechnol.15, 976–979. [DOI] [PubMed]
  27. Schuch, R., Nelson, D. & Fischetti, V. A. (2002). Nature (London), 418, 884–889. [DOI] [PubMed]
  28. Soni, K., Nannapaneni, R. & Hagens, S. (2010). Foodborne Pathog. Dis.7, 427–434. [DOI] [PubMed]
  29. Vocadlo, D. & Davies, G. J. (2008). Curr. Opin. Chem. Biol.12, 539–555. [DOI] [PubMed]
  30. Yoong, P., Schuch, R., Nelson, D. & Fischetti, V. A. (2004). J. Bacteriol.186, 4808–4812. [DOI] [PMC free article] [PubMed]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

PDB reference: family GH25 lysozyme, 2x8r


Articles from Acta Crystallographica Section F: Structural Biology and Crystallization Communications are provided here courtesy of International Union of Crystallography

RESOURCES